Jupiter Neurosciences (JUNS) Accumulated Expenses (2023 - 2025)

Jupiter Neurosciences (JUNS) has reported Accumulated Expenses for 3 consecutive years, with $39829.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Accumulated Expenses rose 3643.33% year-over-year to $39829.0; the TTM figure through Dec 2025 stood at $39829.0 (up 3643.33% YoY), while the FY2025 annual figure was $39829.0, up 3643.33% from the prior year.
• Accumulated Expenses slipped to $39829.0 in Q4 2025 per JUNS's latest filing, from $1.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.9 million in Q2 2025 and bottomed at $1064.0 in Q4 2024.
• Historically, Accumulated Expenses has averaged $576640.9 across 3 years, with a median of $88000.0 in 2023.
• Annual changes were most pronounced in 2024 — Accumulated Expenses slumped 98.79% — and 2025, when it soared 3643.33%.
• Jupiter Neurosciences' Accumulated Expenses stood at $88000.0 in 2023, then plunged by 98.79% to $1064.0 in 2024, then jumped by 3643.33% to $39829.0 in 2025.
• Business Quant data shows JUNS's Accumulated Expenses at $39829.0 in Q4 2025, $1.8 million in Q3 2025, and $1.9 million in Q2 2025.